Literature DB >> 15024055

Identification of Staufen in the human immunodeficiency virus type 1 Gag ribonucleoprotein complex and a role in generating infectious viral particles.

Laurent Chatel-Chaix1, Jean-Francois Clément, Catherine Martel, Véronique Bériault, Anne Gatignol, Luc DesGroseillers, Andrew J Mouland.   

Abstract

Staufen is a host protein that is selectively incorporated into human immunodeficiency virus type 1 (HIV-1) particles in a poorly defined process that involves the selection of HIV-1 genomic RNA for encapsidation and the activity of its third double-stranded RNA-binding domain (dsRBD3). To better understand this, we characterized its interactions with pr55(Gag), the principal mediator of HIV-1 genomic RNA encapsidation. Chimeric proviruses harboring wild-type or mutant forms of Staufen were expressed in 293T cells. Cell fractionation analyses demonstrated that Staufen cosedimented with pr55(Gag) within detergent-resistant, trypsin-sensitive complexes that excluded mature capsid and matrix proteins. Coimmunoprecipitation and bioluminescence resonance energy transfer assays demonstrated a specific and direct interaction between Staufen and the nucleocapsid domain of pr55(Gag) in vitro and in live cells. This interaction is shown here to be mediated by Staufen's dsRBD3, with a contribution from its C-terminal domain. Immunoprecipitation and reverse transcription-PCR analyses showed that the 9-kb genomic RNA was found within Staufen-containing immune complexes. Spliced HIV-1 RNAs were not detected in these Staufen complexes, indicating a preferential association of Staufen with the 9-kb species. These results substantiate that Staufen and pr55(Gag) interact directly during HIV-1 expression. Knockdown of Staufen expression by small interfering RNAs in HIV-1-expressing cells demonstrated that this cellular protein was important for the generation of infectious virus. These data show that Staufen, pr55(Gag), and genomic RNA are part of the same intracellular complex and support a role for Staufen in pr55(Gag) function in viral assembly, genomic RNA encapsidation, and the generation of infectious viral particles.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15024055      PMCID: PMC371130          DOI: 10.1128/MCB.24.7.2637-2648.2004

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  50 in total

1.  RNA-RNA interaction is required for the formation of specific bicoid mRNA 3' UTR-STAUFEN ribonucleoprotein particles.

Authors:  D Ferrandon; I Koch; E Westhof; C Nüsslein-Volhard
Journal:  EMBO J       Date:  1997-04-01       Impact factor: 11.598

2.  Oncogenic potential of TAR RNA binding protein TRBP and its regulatory interaction with RNA-dependent protein kinase PKR.

Authors:  M Benkirane; C Neuveut; R F Chun; S M Smith; C E Samuel; A Gatignol; K T Jeang
Journal:  EMBO J       Date:  1997-02-03       Impact factor: 11.598

3.  Gag-Gag interactions in the C-terminal domain of human immunodeficiency virus type 1 p24 capsid antigen are essential for Gag particle assembly.

Authors:  W H Zhang; D J Hockley; M V Nermut; Y Morikawa; I M Jones
Journal:  J Gen Virol       Date:  1996-04       Impact factor: 3.891

4.  Inactivation of the human immunodeficiency virus type 1 inhibitory elements allows Rev-independent expression of Gag and Gag/protease and particle formation.

Authors:  R Schneider; M Campbell; G Nasioulas; B K Felber; G N Pavlakis
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

5.  The intracellular localization of messenger RNAs.

Authors:  D St Johnston
Journal:  Cell       Date:  1995-04-21       Impact factor: 41.582

6.  Functional domains of the capsid protein of human immunodeficiency virus type 1.

Authors:  T Dorfman; A Bukovsky; A Ohagen; S Höglund; H G Göttlinger
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

7.  Formation of virus assembly intermediate complexes in the cytoplasm by wild-type and assembly-defective mutant human immunodeficiency virus type 1 and their association with membranes.

Authors:  Y M Lee; B Liu; X F Yu
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

8.  A new reporter cell line to monitor HIV infection and drug susceptibility in vitro.

Authors:  A Gervaix; D West; L M Leoni; D D Richman; F Wong-Staal; J Corbeil
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

9.  Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity.

Authors:  D F Purcell; M A Martin
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

10.  Crystal structures of the trimeric human immunodeficiency virus type 1 matrix protein: implications for membrane association and assembly.

Authors:  C P Hill; D Worthylake; D P Bancroft; A M Christensen; W I Sundquist
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-02       Impact factor: 11.205

View more
  72 in total

1.  Characterization of Staufen 1 ribonucleoprotein complexes.

Authors:  Cornelia Brendel; Monika Rehbein; Hans-Jürgen Kreienkamp; Friedrich Buck; Dietmar Richter; Stefan Kindler
Journal:  Biochem J       Date:  2004-12-01       Impact factor: 3.857

2.  Human Staufen1 protein interacts with influenza virus ribonucleoproteins and is required for efficient virus multiplication.

Authors:  Susana de Lucas; Joan Peredo; Rosa María Marión; Carmen Sánchez; Juan Ortín
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

Review 3.  Properties and functions of the nucleocapsid protein in virus assembly.

Authors:  Delphine Muriaux; Jean-Luc Darlix
Journal:  RNA Biol       Date:  2010-11-01       Impact factor: 4.652

4.  The cellular protein lyric interacts with HIV-1 Gag.

Authors:  Christine E Engeland; Heike Oberwinkler; Michael Schümann; Eberhard Krause; Gerd A Müller; Hans-Georg Kräusslich
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

5.  Genetic analysis of influenza virus NS1 gene: a temperature-sensitive mutant shows defective formation of virus particles.

Authors:  Urtzi Garaigorta; Ana M Falcón; Juan Ortín
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

Review 6.  Plunder and stowaways: incorporation of cellular proteins by enveloped viruses.

Authors:  Réjean Cantin; Sylvie Méthot; Michel J Tremblay
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

7.  Puralpha as a cellular co-factor of Rev/RRE-mediated expression of HIV-1 intron-containing mRNA.

Authors:  Rafal Kaminski; Nune Darbinian; Bassel E Sawaya; Dorota Slonina; Shohreh Amini; Edward M Johnson; Jay Rappaport; Kamel Khalili; Armine Darbinyan
Journal:  J Cell Biochem       Date:  2008-03-01       Impact factor: 4.429

8.  Unexpected roles for UPF1 in HIV-1 RNA metabolism and translation.

Authors:  Lara Ajamian; Levon Abrahamyan; Miroslav Milev; Pavel V Ivanov; Andreas E Kulozik; Niels H Gehring; Andrew J Mouland
Journal:  RNA       Date:  2008-03-27       Impact factor: 4.942

Review 9.  Nonsense-mediated mRNA decay in human cells: mechanistic insights, functions beyond quality control and the double-life of NMD factors.

Authors:  Pamela Nicholson; Hasmik Yepiskoposyan; Stefanie Metze; Rodolfo Zamudio Orozco; Nicole Kleinschmidt; Oliver Mühlemann
Journal:  Cell Mol Life Sci       Date:  2009-10-27       Impact factor: 9.261

Review 10.  How HIV-1 Gag assembles in cells: Putting together pieces of the puzzle.

Authors:  Jaisri R Lingappa; Jonathan C Reed; Motoko Tanaka; Kasana Chutiraka; Bridget A Robinson
Journal:  Virus Res       Date:  2014-07-24       Impact factor: 3.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.